Services | ABNewswire

Marketing Strategist Katina Ndlovu Demonstrates How Google Local Services Ads Can Deliver High-Intent Leads for Service Businesses

Service businesses do not fail because of a lack of visibility. They fail when demand arrives at the wrong moment or in the wrong form. This case study shows what happens when marketing is designed around how real customers decide, … Continue reading →

Triple-Negative Breast Cancer Clinical Trial Arena Broadens With 170+ Pipeline Candidates, Reports DelveInsight

Triple Negative Breast Cancer Pipeline Insight A growing number of innovative therapies for triple-negative breast cancer (TNBC) – including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) – are expected … Continue reading →

Colorectal Cancer Competitive Landscape: 195+ Companies Advancing 200+ Clinical-Stage Therapies Across Global Trials, Reports DelveInsight

Colorectal Cancer Competitive Landscape Leading companies active in the colorectal cancer space include Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius Biotech, Sumitomo Pharma Oncology, Purple Biotech Ltd., Amgen, Mirati Therapeutics, … Continue reading →

Muscle Invasive Bladder Cancer Competitive Landscape: Insights Into 10+ Companies, 10+ Pipeline Drugs, and Phase I–III Clinical Trials, analyses DelveInsight

Muscle Invasive Bladder Cancer Competitive Landscape Leading companies operating in the Muscle Invasive Bladder Cancer (MIBC) space include Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC, Asieris Pharmaceuticals, RemeGen Co., Ltd., along with several other global … Continue reading →

Severe Asthma Clinical Trial Analysis: In-Depth Analysis of 50+ Novel Therapies Being Advanced by 40+ Companies, Reports DelveInsight

Severe Asthma Clinical Trial Prominent companies actively shaping the severe asthma treatment space include Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical … Continue reading →

Obesity Clinical Trial Landscape Broadens With 100+ Novel Therapies, Says DelveInsight

Obesity Clinical Trial Major companies active in the obesity space include Pfizer, Biolingus, Regor Pharmaceuticals, Zealand Pharma, Sirnaomics, Innovent Biologics, PegBio, NodThera Limited, Sciwind Biosciences, Boehringer Ingelheim, Clearmind Medicine, Sparrow Pharmaceuticals, Genexine, TransThera, Fractyl Health, Shionogi, among others. As per … Continue reading →

B-Cell Lymphoma Treatment Pipeline Shows Strong Momentum as 295+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “B-cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

EGFR + NSCLC Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the EGFR + NSCLC … Continue reading →

Gastric Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight

DelveInsight’s “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Systemic Lupus Erythematosus Treatment Pipeline Shows Strong Momentum as 120+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2025” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Tuesday - February 10, 2026

Category Archives: Services